GB926784A - 2-(4-methylpiperazino)-ethyl-guanidine and process for its manufacture - Google Patents
2-(4-methylpiperazino)-ethyl-guanidine and process for its manufactureInfo
- Publication number
- GB926784A GB926784A GB1705560A GB1705560A GB926784A GB 926784 A GB926784 A GB 926784A GB 1705560 A GB1705560 A GB 1705560A GB 1705560 A GB1705560 A GB 1705560A GB 926784 A GB926784 A GB 926784A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methylpiperazino
- guanidine
- ethyl
- salt
- manufacture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
Abstract
The invention comprises 2-(4-methylpiperazino)-ethyl-guanidine, its physiologically acceptable acid addition salts; the preparation thereof by reacting 2-(4-methylpiperazino)-ethylamine with an S-loweralkyl-iso thiourea or a salt thereof; and pharmaceutical compositions containing them. Pharmaceutical compositions having hypotensive activity comprise the guanidine or a salt thereof together with a carrier and may be formulated as tablets, dragees, capsules or solutions for injection. The compositions may contain other therapeutically active ingredients. Specified salts include the ascorbate and 4-amino-salicylate.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81334959A | 1959-05-15 | 1959-05-15 | |
US81666959A | 1959-05-29 | 1959-05-29 | |
US84855959A | 1959-10-26 | 1959-10-26 | |
US12681A US3098066A (en) | 1960-03-04 | 1960-03-04 | Diaza-heterocyclic guanidine compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB926784A true GB926784A (en) | 1963-05-22 |
Family
ID=27486217
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3187061A Expired GB926624A (en) | 1959-05-15 | 1960-05-13 | New amines and process for their manufacture |
GB1705560A Expired GB926784A (en) | 1959-05-15 | 1960-05-13 | 2-(4-methylpiperazino)-ethyl-guanidine and process for its manufacture |
GB1705460A Expired GB926623A (en) | 1959-05-15 | 1960-05-13 | New guanidines and process for their manufacture |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3187061A Expired GB926624A (en) | 1959-05-15 | 1960-05-13 | New amines and process for their manufacture |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1705460A Expired GB926623A (en) | 1959-05-15 | 1960-05-13 | New guanidines and process for their manufacture |
Country Status (5)
Country | Link |
---|---|
CH (4) | CH390926A (en) |
DK (1) | DK103022C (en) |
ES (1) | ES258082A1 (en) |
GB (3) | GB926624A (en) |
NL (1) | NL251629A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9803536D0 (en) | 1998-02-19 | 1998-04-15 | Black James Foundation | Histamine H,receptor ligands |
-
0
- NL NL251629D patent/NL251629A/xx unknown
-
1960
- 1960-05-04 CH CH1408564A patent/CH390926A/en unknown
- 1960-05-04 CH CH1408764A patent/CH390928A/en unknown
- 1960-05-04 CH CH512460A patent/CH393337A/en unknown
- 1960-05-04 CH CH1408664A patent/CH390927A/en unknown
- 1960-05-13 GB GB3187061A patent/GB926624A/en not_active Expired
- 1960-05-13 GB GB1705560A patent/GB926784A/en not_active Expired
- 1960-05-13 GB GB1705460A patent/GB926623A/en not_active Expired
- 1960-05-14 ES ES0258082A patent/ES258082A1/en not_active Expired
- 1960-05-14 DK DK600860A patent/DK103022C/en active
Also Published As
Publication number | Publication date |
---|---|
DK103022C (en) | 1965-11-08 |
CH390928A (en) | 1965-04-30 |
GB926624A (en) | 1963-05-22 |
CH390927A (en) | 1965-04-30 |
ES258082A1 (en) | 1960-12-01 |
CH393337A (en) | 1965-06-15 |
GB926623A (en) | 1963-05-22 |
CH390926A (en) | 1965-04-30 |
NL251629A (en) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8307794A1 (en) | Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them. | |
BE594422A (en) | Process for the preparation of alkanolamine salts. | |
HU171226B (en) | Insecticide, acaricide and fungicide compositions and process for producing amino-carbonyl-thiobarbituric acid derivatives and salts thereof, utilizable as active agent | |
CH405320A (en) | Process for the preparation of new N, N-disubstituted piperazines | |
GB824908A (en) | Improvements in or relating to triazine derivatives | |
GB926784A (en) | 2-(4-methylpiperazino)-ethyl-guanidine and process for its manufacture | |
MY6500128A (en) | Quaternary ammonium compounds, the preparation thereof & pharmaceutical compositions thereof | |
GB1062137A (en) | Optically active -a-(pyrrolidino-methyl)-valerophenone and process for its manufacture | |
GB914524A (en) | Thiazole carboxylic acid-(5-nitrofuryl-2-methylidene)-hydrazides and process for their manufacture | |
GB1402085A (en) | 15-hydroxy vincamine | |
GB912126A (en) | Sulphamoyl benzothiadiazine derivative | |
ES8304924A1 (en) | Peptide, process for preparation thereof and use thereof. | |
FR2547820B1 (en) | PERIPHERAL OPIACEOUS ANTAGONISTS | |
GB939251A (en) | 4-chloro-6-fluorobenzene-1,3-disulphonamide and a method of preparing it | |
GB929797A (en) | Sulphonamides | |
GB982615A (en) | Improvements in or relating to 3-methyl-1,2,4-benzothiadiazine-1,1-dioxide | |
GB838759A (en) | 5-(ú¤-substituted-phenoxy-methyl)-2-oxazolidone compounds and their preparation | |
GB824011A (en) | Pharmaceutical compositions containing 1-methyl-6-nitro-4-quinolone-3-carboxylic acid | |
GB933605A (en) | Pharmaceutical preparations containing cyclopropane carboxylic acid and the salts thereof | |
GB911499A (en) | D-ª--methyltryptamine and acid addition salts thereof | |
GB1000781A (en) | ª-morpholinobutyrophenone and its salts | |
GB884576A (en) | Pharmaceutical compositions comprising an alkylamino substituted barbituric acid and salts thereof | |
ES8304925A1 (en) | New peptide, process for preparation thereof and use thereof. | |
GB913435A (en) | Improvements in or relating to beta-cyclopentylpropionic ester | |
GB860380A (en) | Improvements in or relating to halogenated oxathianes and oxathienes |